Giles Monnickendam

Giles Monnickendam is a highly experienced professional in health economics and market access, currently serving as Director at Ceelos Consulting since November 2018, while also holding a position as a Committee Member on the Technology Appraisal Committee at NICE since March 2020. Previously, Giles was Director of HEOR at Vitaccess from November 2019 to February 2022, and served as Associate Director at PRMA Consulting Ltd from January 2016 to October 2019, leading various health economics projects for multinational clients. Additional roles include Market Access & Pricing Consultant at Ferring Pharmaceuticals and independent health industry consulting. Giles has experience from finance management positions at Medtronic and strategic planning roles at Novartis Consumer Health and Boots Healthcare International. Academically, Giles holds multiple advanced degrees in health economics and economics from The London School of Economics and UCL, along with a Chartered Management Accountant qualification.